Literature DB >> 8925128

Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours.

N Kamio1.   

Abstract

The development and progression of cancer are known to be regulated by various oncogenes and tumour suppressor genes. We analysed 63 primary malignant salivary gland tumours for the expression of p53 and c-erbB-2 proteins. Immunohistochemically, 7 of 63 tumours (11%) showed diffuse nuclear staining for p53 protein, and all 7 were also positive for c-erbB-2 protein. The overexpression of p53 protein correlated closely with the overexpression of c-erbB-2 protein (P<0.001). Overexpression of both p53 and c-erbB-2 proteins (coexpression) was found in tumours of certain histological types, such as adenocarcinoma, carcinoma in pleomorphic adenoma, and salivary duct carcinoma. Furthermore, it is noteworthy that coexpression was associated with high-grade carcinoma, advanced tumour stage, and a high Ki-67 labelling index (%) which is a marker of cell proliferation. In adenocarcinoma, we attempted to clarify the relationship between coexpression and histological grade. Coexpression was associated with histological grades showing high mitotic indices and necrotic areas, which reflected high cell-proliferative activity. These results suggest that the accumulation of genetic alterations, such as those involving p53 and c-erbB-2, plays an important part in the progression of malignant salivary gland tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8925128     DOI: 10.1007/bf00193934

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.

Authors:  T Nagao; F Kondo; T Sato; Y Nagato; Y Kondo
Journal:  Hum Pathol       Date:  1995-03       Impact factor: 3.466

2.  p53 expression and prognosis in gastric carcinoma.

Authors:  H M Martin; M I Filipe; R W Morris; D P Lane; F Silvestre
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

3.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

4.  Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.

Authors:  S Sugano; K Mukai; H Tsuda; S Hirohashi; S Furuya; Y Shimosato; S Ebihara; I Takeyama
Journal:  Laryngoscope       Date:  1992-08       Impact factor: 3.325

5.  Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Authors:  J Isola; T Visakorpi; K Holli; O P Kallioniemi
Journal:  J Natl Cancer Inst       Date:  1992-07-15       Impact factor: 13.506

6.  c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands.

Authors:  H Deguchi; H Hamano; Y Hayashi
Journal:  Acta Pathol Jpn       Date:  1993 Jul-Aug

7.  An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis.

Authors:  T Haerslev; G K Jacobsen
Journal:  Hum Pathol       Date:  1995-03       Impact factor: 3.466

8.  Evaluation of malignant grade of salivary gland tumors: studies by cytofluorometric nuclear DNA analysis, histochemistry for nucleolar organizer regions and immunohistochemistry for p53.

Authors:  K Ishii; T Nakajima
Journal:  Pathol Int       Date:  1994-04       Impact factor: 2.534

9.  Adenocarcinoma of salivary origin. Clinicopathologic study of 204 patients.

Authors:  R H Spiro; A G Huvos; E W Strong
Journal:  Am J Surg       Date:  1982-10       Impact factor: 2.565

10.  Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.

Authors:  C A Midgley; C J Fisher; J Bártek; B Vojtĕsek; D Lane; D M Barnes
Journal:  J Cell Sci       Date:  1992-01       Impact factor: 5.285

View more
  9 in total

1.  Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.

Authors:  J C Rosa; A Félix; I Fonseca; J Soares
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 2.  [Diagnosis and prognosis of salivary gland tumors. An interpretation of new revised WHO classification].

Authors:  G Seifert
Journal:  Mund Kiefer Gesichtschir       Date:  1997-09

3.  [Salivary duct carcinoma of the submandibular gland].

Authors:  M Jaehne; A Dippel; C Sagowski
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

Review 4.  Salivary mucoepidermoid carcinoma revisited.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Asterios Triantafyllou; Jennifer L Hunt; Alessandra Rinaldo; Primož Strojan; Missak Haigentz; William M Mendenhall; Robert P Takes; Vincent Vander Poorten; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-26       Impact factor: 2.503

5.  Myoepithelial carcinoma (malignant myoepithelioma) of the parotid gland arising in a pleomorphic adenoma.

Authors:  W G McCluggage; W J Primrose; P G Toner
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

6.  Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour.

Authors:  A Etges; D S Pinto; L P Kowalski; F A Soares; V C Araújo
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

7.  Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma.

Authors:  Wen-Ting Liao; Ling Guo; Yi Zhong; Yan-Heng Wu; Jun Li; Li-Bing Song
Journal:  J Transl Med       Date:  2011-12-01       Impact factor: 5.531

8.  Salivary duct carcinoma of the parotid gland.

Authors:  Mona Mlika; Nadia Kourda; Ysh Zidi; Raoudha Aloui; Nadia Zneidi; Soumaya Rammeh; Rachida Zermani; Sarah Ben Jilani
Journal:  J Oral Maxillofac Pathol       Date:  2012-01

9.  Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review.

Authors:  Cheng-Chieh Hsu; Wing-Yin Li; Pen-Yuan Chu
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.